{"transactions":[{"id":728640,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728639,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728638,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728637,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":121745,"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":739180,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:18:10.000Z","date":"2026-06-10","kind":"gift","planned":false,"acquired":true,"shares":14048,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person and her spouse are the trustees and beneficiaries. The reporting person continues to beneficially own these securities held by the trust."}],"balance_after":14048,"derivative":{"exercise_price":10.69,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":14048},"source":{"system":"sec-edgar","filing":"0001829248-26-000004","document":"form4-06122026_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000182924826000004/form4-06122026_080606.xml","form_type":"4"}},{"id":739179,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:18:10.000Z","date":"2026-06-10","kind":"gift","planned":false,"acquired":false,"shares":14048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."}],"balance_after":0,"derivative":{"exercise_price":10.69,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":14048},"source":{"system":"sec-edgar","filing":"0001829248-26-000004","document":"form4-06122026_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000182924826000004/form4-06122026_080606.xml","form_type":"4"}},{"id":744234,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T22:25:21.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027."}],"balance_after":6530,"source":{"system":"sec-edgar","filing":"0001829248-26-000002","document":"form4-06092026_100617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000182924826000002/form4-06092026_100617.xml","form_type":"4"}},{"id":767485,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T22:30:02.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":4.1715,"value":25446.15,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as \"May 18, 2025\" instead of \"May 18, 2026.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92145,"source":{"system":"sec-edgar","filing":"0001193125-26-235039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526235039/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-20"}},{"id":769595,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:15:21.000Z","date":"2025-05-18","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":4.1715,"value":25446.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92145,"source":{"system":"sec-edgar","filing":"0001193125-26-232612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526232612/ownership.xml","form_type":"4"}},{"id":1102391,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were fully vested as of June 20, 2025"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were fully vested as of June 20, 2025"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102390,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102389,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102388,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":86045,"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1130218,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2025-05-28","kind":"gift","planned":false,"acquired":true,"shares":8153,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust."}],"balance_after":8153,"derivative":{"exercise_price":14.83,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8153},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1130217,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2025-05-28","kind":"gift","planned":false,"acquired":false,"shares":8153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."}],"balance_after":0,"derivative":{"exercise_price":14.83,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8153},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1130216,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":11645,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust."}],"balance_after":11645,"derivative":{"exercise_price":9.58,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":11645},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1130215,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":false,"shares":11645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."}],"balance_after":0,"derivative":{"exercise_price":9.58,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":11645},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1130214,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust."}],"balance_after":16300,"derivative":{"exercise_price":8.31,"expiration_date":"2032-09-12","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1130213,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:21:17.000Z","date":"2024-06-24","kind":"gift","planned":false,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vested."}],"balance_after":0,"derivative":{"exercise_price":8.31,"expiration_date":"2032-09-12","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001415889-25-014864","document":"form4-05292025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925014864/form4-05292025_080514.xml","form_type":"4"}},{"id":1138639,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-21T20:42:26.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":14048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option will vest and become exercisable on April 30, 2026, or if earlier, the date of the Company's 2026 Annual Meeting of Stockholders."}],"balance_after":14048,"derivative":{"exercise_price":10.69,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":14048},"source":{"system":"sec-edgar","filing":"0001415889-25-013945","document":"form4-05212025_080522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000141588925013945/form4-05212025_080522.xml","form_type":"4"}},{"id":1471713,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:54:16.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.44,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-24-076363","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024076363/ownership.xml","form_type":"4"}},{"id":1471712,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T21:54:16.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-24-076363","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024076363/ownership.xml","form_type":"4"}},{"id":1474675,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:00:14.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unites are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-24-074989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024074989/ownership.xml","form_type":"4"}},{"id":1474674,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T21:00:14.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":56445,"source":{"system":"sec-edgar","filing":"0000950170-24-074989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024074989/ownership.xml","form_type":"4"}},{"id":1488039,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-06T20:16:09.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":8153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Option will vest and become exercisable on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders."}],"balance_after":8153,"derivative":{"exercise_price":14.83,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8153},"source":{"system":"sec-edgar","filing":"0001062993-24-012032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000106299324012032/form4.xml","form_type":"4"}},{"id":1847523,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T20:05:34.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":46750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":46750,"derivative":{"exercise_price":4.12,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":46750},"source":{"system":"sec-edgar","filing":"0000899243-23-016129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924323016129/doc4.xml","form_type":"4"}},{"id":1847522,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T20:05:34.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":33150,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000899243-23-016129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924323016129/doc4.xml","form_type":"4"}},{"id":1888370,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-17T20:26:37.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":11645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders."}],"balance_after":11645,"derivative":{"exercise_price":9.58,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":11645},"source":{"system":"sec-edgar","filing":"0001062993-23-011389","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000106299323011389/form4.xml","form_type":"4"}},{"id":2104900,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T21:10:24.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":5000,"price":9.6766,"value":48383.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $9.6500 to $9.7000 inclusive.  The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001062993-22-022722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000106299322022722/form4.xml","form_type":"4"}},{"id":2159123,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-09-14T20:06:42.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders."}],"balance_after":16300,"derivative":{"exercise_price":8.31,"expiration_date":"2032-09-12","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001437749-22-022425","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000143774922022425/rdgdoc.xml","form_type":"4"}},{"id":2159122,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-09-14T20:06:42.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2,500 shares vest on each of 9/12/23, 9/12/24, 9/12/25 and 9/12/26."}],"balance_after":10000,"derivative":{"exercise_price":8.31,"expiration_date":"2032-09-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-22-022425","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603454/000143774922022425/rdgdoc.xml","form_type":"4"}},{"id":2224903,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T23:47:19.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":61264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":61264,"derivative":{"exercise_price":6.5,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":61264},"source":{"system":"sec-edgar","filing":"0000899243-22-023501","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924322023501/doc4.xml","form_type":"4"}},{"id":2462084,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T02:41:07.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":12000,"price":8.5663,"value":102795.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.66, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":23295,"source":{"system":"sec-edgar","filing":"0000899243-21-049313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924321049313/doc4.xml","form_type":"4"}},{"id":2660006,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T21:30:10.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":34025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":34025,"derivative":{"exercise_price":23.39,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":34025},"source":{"system":"sec-edgar","filing":"0000899243-21-025037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924321025037/doc4.xml","form_type":"4"}},{"id":2994197,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-1 Convertible Preferred Stock","published_at":"2020-11-04T01:09:34.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":4173,"ownership":{"direct":false,"nature":"Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4173},"source":{"system":"sec-edgar","filing":"0000899243-20-030332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030332/doc4.xml","form_type":"4"}},{"id":2994196,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2020-11-04T01:09:34.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":7122,"ownership":{"direct":false,"nature":"Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7122},"source":{"system":"sec-edgar","filing":"0000899243-20-030332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030332/doc4.xml","form_type":"4"}},{"id":2994195,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T01:09:34.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":11295,"ownership":{"direct":false,"nature":"Held by the Marc & Polly Murphy Revocable Family Trust dated March 13, 2002"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":11295,"source":{"system":"sec-edgar","filing":"0000899243-20-030332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030332/doc4.xml","form_type":"4"}}]}